Busca un médico

Homan Mohammadi, M.D.

  1. Radiation Oncologist

Location

  1. Jacksonville, Florida

Idiomas

EnglishPersianGerman

Appointments

Dr. Homan Mohammadi is a board-certified radiation oncologist at Mayo Clinic in Jacksonville, Florida, specializing in precision radiation therapy for patients with head and neck cancers, prostate cancer, bladder cancer, renal cell cancer, and skin cancers of the head and neck. He combines advanced radiation techniques with multidisciplinary cancer care to deliver personalized treatment plans that maximize effectiveness while minimizing side effects.

Before joining Mayo Clinic, Dr. Mohammadi served as a faculty radiation oncologist at Dana-Farber Cancer Institute/Brigham and Women's Cancer Center and as an Instructor at Harvard Medical School. He earned his medical degree from the George Washington University School of Medicine and Health Sciences and completed his residency in radiation oncology at Moffitt Cancer Center.

Dr. Mohammadi has expertise in volumetric modulated arc therapy (VMAT), intensity-modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT). He works closely with medical oncologists, surgeons, radiologists, pathologists and other specialists to develop individualized treatment plans that integrate radiation therapy into each patient's overall cancer care.

His research interests focus on advancing personalized radiation oncology through innovative radiotherapy techniques, clinical trials and particle therapy. He is dedicated to improving treatment accuracy and reducing radiation-related side effects, with the goal of improving outcomes and quality of life for patients with cancer.

"My purpose is to deliver the most precise and effective radiation treatment that is best aligned with my patients' goals," says Dr. Mohammadi. "By combining rapidly advancing technology with a multidisciplinary approach, we can tailor treatments to each patient's cancer while minimizing side effects to achieve the best possible outcome."

Outside of medicine, Dr. Mohammadi enjoys snowboarding, rock climbing, reading, and traveling.

  1. Bladder cancer
  2. Head and neck cancer
  3. Hypopharyngeal cancer
  4. Laryngeal cancer
  5. Nasopharyngeal carcinoma
  6. Oral and throat cancer
  7. Oropharyngeal cancer
  8. Prostate cancer
  9. Salivary gland cancer
  10. Skin cancer
  11. Thyroid cancer
  1. 2021
    Residency - Radiation Oncology H. Lee Moffitt Cancer and Research Center
  2. 2017
    Transitional Resident - Transitional YearIndiana University
  3. 2016
    MDGeorge Washington University School of Medicine and Health Sciences
  4. 2010
    BS - Medical TechnologyUniversity of Maryland

Certifications

  1. 2022
    Radiation OncologyAmerican Board of Radiology

Awards and honors

  1. 2026
    Most Cited Paper AwardJGO
  2. 2026
    2026 Florida campus Excellence in Education and Teacher of the Year Award Excellence in Education Award
  3. 2022
    Travel Grant AwardAmerican Radium Society
  4. 2021
    Travel Grant AwardAmerican Radium Society
  5. 2021
    Quality Improvement’s Great Catch Award Brigham and Women's Cancer Center, Dana-Farber Cancer Institute
  6. 2020
    Recipient Thomas J. Dilling Clinical Education AwardH. Lee Moffitt Cancer Center & Research Institute
  7. 2020
    Recipient of the Best of ASTRO awardAmerican Society for Radiation Oncology
  8. 2018
    Recipient Kassan Research AwardGeorge Washington University School of Medicine and Health Sciences
  9. 2016
    RecipientMax Kade Fellowship, American Austrian Foundation
  10. 2015
    InducteeGold Humanism Honor Society
  11. 2013
    Recipient of the Gill Research FellowshipNational Institutes of Health
  12. 2010
    Department Chair's Award for Professional Role Model University of Maryland
  13. 2009
    First PlaceBaltimore County, University of Maryland
  14. 2009
    Third placeRegion II Case Study Contest, American Society for Clinical Pathology

Professional memberships

  1. 2026 - present
    GU Disease Site SubCommittee InvolvementParticle Therapy Cooperative Group (PTCOG)
  2. 2026 - present
    Head and Neck SubcommitteeParticle Therapy Cooperative Group (PTCOG)
  3. 2026 - present
    Carbon Ion Therapy SubcommitteeParticle Therapy Cooperative Group (PTCOG)
  4. 2026 - present
    Invited ContributorTheMednet
  5. 2026 - present
    Invited Expert ContributortheMednet.org
  6. 2025 - present
    MemberMayo Clinic Comprehensive Cancer Center
  7. 2025
    MemberCOMPASS+ Connection Group
  8. 2025 - present
    H&N Disease Site SubCommittee InvolvementParticle Therapy Cooperative Group - North America (PTCOG-NA)
  9. 2024 - present
    MemberDepartment Belonging Leader
  10. 2024 - present
    MemberReirradiation Collaborative Group (ReCOG)
  11. 2024 - present
    LiaisonMayo Clinic Comprehensive Cancer Center, Plan to Enhance Diversity (PED) Liaison for the Head and Neck Disease Group
  12. 2024 - present
    MemberClinical Competency Committee, Residency Program
  13. 2022 - 2023
    MemberRadiation Oncology IV Contrast Committee, Dana-Farber Cancer Institute/Brigham Cancer Center
  14. 2021 - 2026
    MemberASTRO Congressional Relations Subcommittee
  15. 2021 - present
    MemberAmerican Society of Therapeutic Radiation Oncology
  16. 2020 - 2021
    Co-DirectorMultidisciplinary Leadership Journal Club, Moffitt Cancer Center
  17. 2019
    ReviewerScientific Symposium Committee, Moffitt Cancer Center
  18. 2018 - 2021
    Resident RepresentativeAccreditation Council for Graduate Medical Education, H. Lee Moffitt Cancer Center
  19. 2018 - 2021
    Resident Physician and Medical Student LiaisonH. Lee Moffitt Cancer Center
  20. 2018 - 2019
    Resident RepresentativeRadiological Society of North America

Publications